Blog Keep up to date with our latest expert insights into the world of genomic healthcare. FEATURED Let’s Go Dotty for Lynch Syndrome – bridging the gap between testing and diagnosis FEATURED The NEW clinically validated NGS and bioinformatics solution for hereditary cancer testing: GALEAS Hereditary Plus – All you need to know Load More SEARCHSubmitCategoriesAll CategoriesCell3 DirectCell3 targetCustomGermlineInfectious diseaseOncologyPre-analyticalUncategorized Detecting copy number variants using Next Generation Sequencing June 30, 2023 Can you use NGS panels to test for tumor mutational burden? April 24, 2023 What is targeted next generation sequencing? March 31, 2023 The importance of using an optimized pre-analytical workflow for liquid biopsy analysis February 14, 2023 5 Tips for using the Nonacus Panel Design Tool December 20, 2022 COVID-19, Flu and RSV – What makes them different? September 28, 2022 Liquid biopsy: The future of minimal residual disease detection? March 24, 2022 Detecting multiple respiratory viruses with a single qRT-PCR assay March 16, 2022 Unique molecular identifiers: the key to unmasking real low frequency variants January 28, 2022 Tumour Mutational Burden (TMB) and Microsatellite Instability (MSI) as markers for immunotherapy response December 22, 2021 Pages: 123Load more Blog Posts Sign up to receive updates